343 related articles for article (PubMed ID: 29395628)
21. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
Cho LP; Manuel M; Catalano P; Lee L; Damato AL; Cormack RA; Buzurovic I; Bhagwat M; O'Farrell D; Devlin PM; Viswanathan AN
Gynecol Oncol; 2016 Dec; 143(3):545-551. PubMed ID: 27720445
[TBL] [Abstract][Full Text] [Related]
22. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
King M; McConkey C; Latief TN; Hartley A; Fernando I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):38-45. PubMed ID: 16477918
[TBL] [Abstract][Full Text] [Related]
23. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
24. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
25. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
27. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
29. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study.
Eifel PJ; Moughan J; Erickson B; Iarocci T; Grant D; Owen J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1144-53. PubMed ID: 15519786
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
31. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Rakovitch E; Fyles AW; Pintilie M; Leung PM
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):979-87. PubMed ID: 9276362
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
35. Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
Espenel S; Garcia MA; Vallard A; Langrand-Escure J; Guy JB; Trone JC; Ben Mrad M; Chauleur C; de Laroche G; Moreno-Acosta P; Rancoule C; Magné N
Cancer Radiother; 2018 Dec; 22(8):790-796. PubMed ID: 30348607
[TBL] [Abstract][Full Text] [Related]
36. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
Christie DR; Bull CA; Gebski V; Langlands AO
Radiother Oncol; 1995 Dec; 37(3):181-9. PubMed ID: 8746586
[TBL] [Abstract][Full Text] [Related]
37. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
38. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review.
Ring KL; Young JL; Dunlap NE; Andersen WA; Schneider BF
Am J Obstet Gynecol; 2009 Jul; 201(1):109.e1-6. PubMed ID: 19398095
[TBL] [Abstract][Full Text] [Related]
39. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
[TBL] [Abstract][Full Text] [Related]
40. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
Small W; Winter K; Levenback C; Iyer R; Gaffney D; Asbell S; Erickson B; Jhingran A; Greven K
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1081-7. PubMed ID: 17398031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
